Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 51

1.

Authors' Reply to Gandjour: "Are Current Cost-Effectiveness Thresholds for Low- and Middle-Income Countries Useful? Examples from the World of Vaccines"

Newall AT, Jit M, Hutubessy R.

Pharmacoeconomics. 2014 Nov 6. [Epub ahead of print] No abstract available.

PMID:
25374292
[PubMed - as supplied by publisher]
2.

Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study.

Jit M, Brisson M, Portnoy A, Hutubessy R.

Lancet Glob Health. 2014 Jul;2(7):e406-14. doi: 10.1016/S2214-109X(14)70237-2. Epub 2014 Jun 9.

PMID:
25103394
[PubMed - in process]
Free Article
3.

Reassessing the value of vaccines.

Bärnighausen T, Berkley S, Bhutta ZA, Bishai DM, Black MM, Bloom DE, Constenla D, Driessen J, Edmunds J, Evans D, Griffiths U, Hansen P, Hashmani FN, Hutubessy R, Jamison DT, Jha P, Jit M, Johnson H, Laxminarayan R, Lee BY, Mhatre S, Mills A, Nordström A, Ozawa S, Prosser L, Silver K, Benn CS, Standaert B, Walker D.

Lancet Glob Health. 2014 May;2(5):e251-2. doi: 10.1016/S2214-109X(13)70170-0. Epub 2014 Apr 23. No abstract available.

PMID:
25103158
[PubMed - in process]
Free Article
4.

Costs of introducing and delivering HPV vaccines in low and lower middle income countries: inputs for GAVI policy on introduction grant support to countries.

Levin A, Wang SA, Levin C, Tsu V, Hutubessy R.

PLoS One. 2014 Jun 26;9(6):e101114. doi: 10.1371/journal.pone.0101114. eCollection 2014.

PMID:
24968002
[PubMed - in process]
Free PMC Article
5.

Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines.

Newall AT, Jit M, Hutubessy R.

Pharmacoeconomics. 2014 Jun;32(6):525-31. doi: 10.1007/s40273-014-0162-x.

PMID:
24791735
[PubMed - in process]
6.

Fiscal consequences of changes in morbidity and mortality attributed to rotavirus immunisation.

Kotsopoulos N, Connolly MP, Postma MJ, Hutubessy RC.

Vaccine. 2013 Nov 4;31(46):5430-4. doi: 10.1016/j.vaccine.2013.09.002. Epub 2013 Sep 18.

PMID:
24055088
[PubMed - indexed for MEDLINE]
7.

Comparing sociocultural features of cholera in three endemic African settings.

Schaetti C, Sundaram N, Merten S, Ali SM, Nyambedha EO, Lapika B, Chaignat CL, Hutubessy R, Weiss MG.

BMC Med. 2013 Sep 18;11:206. doi: 10.1186/1741-7015-11-206.

PMID:
24047241
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Sociocultural determinants of anticipated vaccine acceptance for acute watery diarrhea in early childhood in Katanga Province, Democratic Republic of Congo.

Merten S, Schaetti C, Manianga C, Lapika B, Hutubessy R, Chaignat CL, Weiss M.

Am J Trop Med Hyg. 2013 Sep;89(3):419-25. doi: 10.4269/ajtmh.12-0643. Epub 2013 Jul 22.

PMID:
23878187
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: a systematic review.

Fesenfeld M, Hutubessy R, Jit M.

Vaccine. 2013 Aug 20;31(37):3786-804. doi: 10.1016/j.vaccine.2013.06.060. Epub 2013 Jul 3. Review.

PMID:
23830973
[PubMed - indexed for MEDLINE]
10.

Influenza vaccines in low and middle income countries: a systematic review of economic evaluations.

Ott JJ, Klein Breteler J, Tam JS, Hutubessy RC, Jit M, de Boer MR.

Hum Vaccin Immunother. 2013 Jul;9(7):1500-11. doi: 10.4161/hv.24704. Epub 2013 May 31. Review.

PMID:
23732900
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Distinguishing social and cultural features of cholera in urban and rural areas of Western Kenya: Implications for public health.

Nyambedha EO, Sundaram N, Schaetti C, Akeyo L, Chaignat CL, Hutubessy R, Weiss MG.

Glob Public Health. 2013;8(5):534-51. doi: 10.1080/17441692.2013.787107. Epub 2013 May 14.

PMID:
23672503
[PubMed - indexed for MEDLINE]
12.

Q&A--Economic analyses for vaccine introduction decisions in low- and middle- income countries.

Hutubessy R.

BMC Med. 2013 Mar 14;11:71. doi: 10.1186/1741-7015-11-71. No abstract available.

PMID:
23496946
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts.

Jit M, Levin C, Brisson M, Levin A, Resch S, Berkhof J, Kim J, Hutubessy R.

BMC Med. 2013 Jan 30;11:23. doi: 10.1186/1741-7015-11-23.

PMID:
23363734
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Local perceptions of cholera and anticipated vaccine acceptance in Katanga province, Democratic Republic of Congo.

Merten S, Schaetti C, Manianga C, Lapika B, Chaignat CL, Hutubessy R, Weiss MG.

BMC Public Health. 2013 Jan 22;13:60. doi: 10.1186/1471-2458-13-60.

PMID:
23339647
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Decision-making on malaria vaccine introduction: the role of cost-effectiveness analyses.

Moorthy VS, Hutubessy R, Newman RD, Hombach J.

Bull World Health Organ. 2012 Nov 1;90(11):864-6. doi: 10.2471/BLT.12.107482. Epub 2012 Sep 19. No abstract available.

PMID:
23226899
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Costs of delivering human papillomavirus vaccination to schoolgirls in Mwanza Region, Tanzania.

Quentin W, Terris-Prestholt F, Changalucha J, Soteli S, Edmunds WJ, Hutubessy R, Ross DA, Kapiga S, Hayes R, Watson-Jones D.

BMC Med. 2012 Nov 13;10:137. doi: 10.1186/1741-7015-10-137.

PMID:
23148516
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

A case study using the United Republic of Tanzania: costing nationwide HPV vaccine delivery using the WHO Cervical Cancer Prevention and Control Costing Tool.

Hutubessy R, Levin A, Wang S, Morgan W, Ally M, John T, Broutet N.

BMC Med. 2012 Nov 13;10:136. doi: 10.1186/1741-7015-10-136.

PMID:
23146319
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries.

Deogaonkar R, Hutubessy R, van der Putten I, Evers S, Jit M.

BMC Public Health. 2012 Oct 16;12:878. doi: 10.1186/1471-2458-12-878. Review.

PMID:
23072714
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar.

Schaetti C, Weiss MG, Ali SM, Chaignat CL, Khatib AM, Reyburn R, Duintjer Tebbens RJ, Hutubessy R.

PLoS Negl Trop Dis. 2012;6(10):e1844. doi: 10.1371/journal.pntd.0001844. Epub 2012 Oct 4.

PMID:
23056660
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study.

Khatib AM, Ali M, von Seidlein L, Kim DR, Hashim R, Reyburn R, Ley B, Thriemer K, Enwere G, Hutubessy R, Aguado MT, Kieny MP, Lopez AL, Wierzba TF, Ali SM, Saleh AA, Mukhopadhyay AK, Clemens J, Jiddawi MS, Deen J.

Lancet Infect Dis. 2012 Nov;12(11):837-44. doi: 10.1016/S1473-3099(12)70196-2. Epub 2012 Sep 4.

PMID:
22954655
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk